Found 35 matching trials
Systems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and Elderly NA Vaccination is the most effective way of preventing infectious diseases. De...
Show More Location
University of Colorado
Learn More & Join Trial
Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients PHASE4 The reactivation of varicella zoster virus (VZV) (herpes zoster (HZ)) is of...
Show More Location
Ha'Emek Medical center, Unit of Rheumatology
Learn More & Join Trial
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy N/A The goal of this observational study is to learn about vaccine immunity in ...
Show More Location
University Hospital Bern
Learn More & Join Trial
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants PHASE2 Primary objectives:
* To assess the safety profile of each SP0202 formulat...
Show More Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Learn More & Join Trial
Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients PHASE4 The purpose of this study is to provide evidence as to whether RZV is immun...
Show More Location
University Hospitals of Geneva
Learn More & Join Trial
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers PHASE1 This is a randomized, active-controlled, dose-escalation multi-center study...
Show More Location
Paratus Clinical Research Western Sydney
Learn More & Join Trial
Immunogenicity and Safety of a 1-dose Regimen of a Zoster Vaccine Versus Different 2-dose Regimens in Participants ≥ 70 Years of Age. (V211-043) PHASE3 Primary objective:
Immunogenicity To demonstrate that a second dose of ZOS...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above PHASE1 The purposes of the study are to evaluate the safety and tolerability of di...
Show More Status
Active Not Recruiting
Location
Yanjin District Center for Disease Control and Prevention
Learn More & Join Trial
Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older PHASE3 The purpose of this study is to assess immunogenicity, reactogenicity and s...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and Older PHASE2 This phase 2 study in China will evaluate the immunogenicity and safety of ...
Show More Status
Active Not Recruiting
Location
Hengnan County Center for Disease Control and Prevention
Learn More & Join Trial